MCRB
Seres Therapeutics Inc
NASDAQ: MCRB · HEALTHCARE · BIOTECHNOLOGY
$7.05
-0.56% today
Updated 2026-04-29
Market cap
$67.91M
P/E ratio
11.02
P/S ratio
86.07x
EPS (TTM)
$0.64
Dividend yield
—
52W range
$7 – $30
Volume
0.1M
Seres Therapeutics Inc (MCRB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
722.00%
Operating margin
-4,424.00%
ROE
19.60%
ROA
-42.20%
Debt/equity
1.95x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-3.13M | — | — | — |
| 2013 | — | $-6.10M | — | — | — |
| 2014 | $0.00 | $-16.71M | — | — | — |
| 2015 | $0.00 | $-54.78M | — | — | — |
| 2016 | $21.77M | $-91.58M | -276.68% | -426.53% | -420.74% |
| 2017 | $32.10M | $-89.38M | -178.68% | -284.72% | -278.44% |
| 2018 | $28.27M | $-98.94M | 100.00% | -354.77% | -350.03% |
| 2019 | $34.51M | $-70.28M | 100.00% | -208.31% | -203.68% |
| 2020 | $33.22M | $-89.13M | -172.68% | -265.33% | -268.33% |
| 2021 | $144.93M | $-65.58M | 100.00% | -44.50% | -45.25% |
| 2022 | $7.13M | $-250.16M | 85.91% | -2,524.05% | -3,509.50% |
| 2023 | $126.33M | $-113.72M | 99.44% | -154.44% | -90.02% |
| 2024 | $0.00 | $136000.00 | — | — | — |
| 2025 | $789000.00 | $5.70M | -423.83% | -11,910.14% | 721.93% |